Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ: AUPH · Real-Time Price · USD
15.25
-0.71 (-4.45%)
At close: Jul 20, 2026, 4:00 PM EDT
15.33
+0.08 (0.52%)
Pre-market: Jul 21, 2026, 4:02 AM EDT
Aurinia Pharmaceuticals Market Cap
Aurinia Pharmaceuticals has a market cap or net worth of $1.96 billion as of July 21, 2026. Its market cap has increased by 68.20% in one year.
Market Cap
1.96B
Enterprise Value
1.65B
1-Year Change
68.20%
Ranking
Category
Stock Price
$15.25
ChartMarket Cap Chart
Since September 3, 2014, Aurinia Pharmaceuticals's market cap has increased from $125.50M to $1.96B, an increase of 1,462.69%. That is a compound annual growth rate of 26.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 1.96B | -6.74% |
| Dec 31, 2025 | 2.10B | 63.56% |
| Dec 31, 2024 | 1.29B | -0.41% |
| Dec 29, 2023 | 1.29B | 110.29% |
| Dec 30, 2022 | 613.90M | -79.30% |
| Dec 31, 2021 | 2.97B | 69.58% |
| Dec 31, 2020 | 1.75B | -8.45% |
| Dec 31, 2019 | 1.91B | 233.25% |
| Dec 31, 2018 | 573.20M | 50.68% |
| Dec 29, 2017 | 380.40M | 366.75% |
| Dec 30, 2016 | 81.50M | 3.69% |
| Dec 31, 2015 | 78.60M | -31.17% |
| Dec 31, 2014 | 114.20M | -9.00% |
| Sep 3, 2014 | 125.50M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Monte Rosa Therapeutics | 2.07B |
| Rapport Therapeutics | 2.04B |
| Syndax Pharmaceuticals | 2.02B |
| Nuvation Bio | 2.02B |
| ADMA Biologics | 2.02B |
| Viridian Therapeutics | 1.99B |
| AbCellera Biologics | 1.97B |
| GH Research | 1.97B |